Head-To-Head Contrast: Phibro Animal Health (NASDAQ:PAHC) & AEON Biopharma (NASDAQ:AEON)

AEON Biopharma (NASDAQ:AEONGet Free Report) and Phibro Animal Health (NASDAQ:PAHCGet Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, analyst recommendations, institutional ownership, dividends, valuation and profitability.

Earnings & Valuation

This table compares AEON Biopharma and Phibro Animal Health’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
AEON Biopharma N/A N/A -$36.63 million N/A N/A
Phibro Animal Health $977.90 million 0.68 $32.61 million $0.32 51.22

Phibro Animal Health has higher revenue and earnings than AEON Biopharma.

Volatility & Risk

AEON Biopharma has a beta of 0.4, indicating that its share price is 60% less volatile than the S&P 500. Comparatively, Phibro Animal Health has a beta of 0.57, indicating that its share price is 43% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of current recommendations for AEON Biopharma and Phibro Animal Health, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AEON Biopharma 0 0 1 0 3.00
Phibro Animal Health 2 1 1 0 1.75

AEON Biopharma presently has a consensus price target of $6.00, indicating a potential upside of 476.92%. Phibro Animal Health has a consensus price target of $14.75, indicating a potential downside of 10.01%. Given AEON Biopharma’s stronger consensus rating and higher probable upside, analysts clearly believe AEON Biopharma is more favorable than Phibro Animal Health.

Insider & Institutional Ownership

22.8% of AEON Biopharma shares are held by institutional investors. Comparatively, 99.3% of Phibro Animal Health shares are held by institutional investors. 20.0% of AEON Biopharma shares are held by company insiders. Comparatively, 50.1% of Phibro Animal Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Profitability

This table compares AEON Biopharma and Phibro Animal Health’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
AEON Biopharma N/A N/A -145.99%
Phibro Animal Health 1.32% 17.11% 4.83%

Summary

Phibro Animal Health beats AEON Biopharma on 8 of the 10 factors compared between the two stocks.

About AEON Biopharma

(Get Free Report)

AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine. AEON Biopharma, Inc. is based in Irvine, California.

About Phibro Animal Health

(Get Free Report)

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, industrial, environmental, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.

Receive News & Ratings for AEON Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AEON Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.